145 related articles for article (PubMed ID: 30983368)
1. Dual-Sensitive Graphene Oxide Loaded with Proapoptotic Peptides and Anticancer Drugs for Cancer Synergetic Therapy.
Zhang J; Chen L; Shen B; Chen L; Mo J; Feng J
Langmuir; 2019 May; 35(18):6120-6128. PubMed ID: 30983368
[TBL] [Abstract][Full Text] [Related]
2. A dual-sensitive mesoporous silica nanoparticle based drug carrier for cancer synergetic therapy.
Zhang J; Shen B; Chen L; Chen L; Meng Y; Feng J
Colloids Surf B Biointerfaces; 2019 Mar; 175():65-72. PubMed ID: 30522009
[TBL] [Abstract][Full Text] [Related]
3. Folic acid-grafted bovine serum albumin decorated graphene oxide: An efficient drug carrier for targeted cancer therapy.
Ma N; Liu J; He W; Li Z; Luan Y; Song Y; Garg S
J Colloid Interface Sci; 2017 Mar; 490():598-607. PubMed ID: 27923144
[TBL] [Abstract][Full Text] [Related]
4. Heparin modified graphene oxide for pH-sensitive sustained release of doxorubicin hydrochloride.
Zhang B; Yang X; Wang Y; Zhai G
Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():198-206. PubMed ID: 28415455
[TBL] [Abstract][Full Text] [Related]
5. Targeted delivery and controlled release of doxorubicin into cancer cells using a multifunctional graphene oxide.
Lv Y; Tao L; Annie Bligh SW; Yang H; Pan Q; Zhu L
Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():652-660. PubMed ID: 26652419
[TBL] [Abstract][Full Text] [Related]
6. Normalization of doxorubicin release from graphene oxide: New approach for optimization of effective parameters on drug loading.
Hashemi M; Yadegari A; Yazdanpanah G; Omidi M; Jabbehdari S; Haghiralsadat F; Yazdian F; Tayebi L
Biotechnol Appl Biochem; 2017 May; 64(3):433-442. PubMed ID: 26878983
[TBL] [Abstract][Full Text] [Related]
7. Amphiphilic prodrug-decorated graphene oxide as a multi-functional drug delivery system for efficient cancer therapy.
Huang C; Wu J; Jiang W; Liu R; Li Z; Luan Y
Mater Sci Eng C Mater Biol Appl; 2018 Aug; 89():15-24. PubMed ID: 29752084
[TBL] [Abstract][Full Text] [Related]
8. Fluorescent graphene oxide via polymer grafting: an efficient nanocarrier for both hydrophilic and hydrophobic drugs.
Kundu A; Nandi S; Das P; Nandi AK
ACS Appl Mater Interfaces; 2015 Feb; 7(6):3512-23. PubMed ID: 25612470
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronic acid-decorated graphene oxide nanohybrids as nanocarriers for targeted and pH-responsive anticancer drug delivery.
Song E; Han W; Li C; Cheng D; Li L; Liu L; Zhu G; Song Y; Tan W
ACS Appl Mater Interfaces; 2014 Aug; 6(15):11882-90. PubMed ID: 25000539
[TBL] [Abstract][Full Text] [Related]
10. Development of biotin molecule targeted cancer cell drug delivery of doxorubicin loaded κ-carrageenan grafted graphene oxide nanocarrier.
Vinothini K; Rajendran NK; Munusamy MA; Alarfaj AA; Rajan M
Mater Sci Eng C Mater Biol Appl; 2019 Jul; 100():676-687. PubMed ID: 30948104
[TBL] [Abstract][Full Text] [Related]
11. Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base.
Li F; Zheng C; Xin J; Chen F; Ling H; Sun L; Webster TJ; Ming X; Liu J
Int J Nanomedicine; 2016; 11():3875-90. PubMed ID: 27574421
[TBL] [Abstract][Full Text] [Related]
12. Tracking the intracellular drug release from graphene oxide using surface-enhanced Raman spectroscopy.
Huang J; Zong C; Shen H; Cao Y; Ren B; Zhang Z
Nanoscale; 2013 Nov; 5(21):10591-8. PubMed ID: 24057012
[TBL] [Abstract][Full Text] [Related]
13. Graphene-based anticancer nanosystem and its biosafety evaluation using a zebrafish model.
Liu CW; Xiong F; Jia HZ; Wang XL; Cheng H; Sun YH; Zhang XZ; Zhuo RX; Feng J
Biomacromolecules; 2013 Feb; 14(2):358-66. PubMed ID: 23286342
[TBL] [Abstract][Full Text] [Related]
14. A Targeted Nano Drug Delivery System of AS1411 Functionalized Graphene Oxide Based Composites.
Liu B; Yang W; Che C; Liu J; Si M; Gong Z; Gao R; Yang G
ChemistryOpen; 2021 Apr; 10(4):408-413. PubMed ID: 33605540
[TBL] [Abstract][Full Text] [Related]
15. Tailored graphene oxide-doxorubicin nanovehicles via near-infrared dye-lactobionic acid conjugates for chemo-photothermal therapy.
Huang C; Hu X; Hou Z; Ji J; Li Z; Luan Y
J Colloid Interface Sci; 2019 Jun; 545():172-183. PubMed ID: 30878783
[TBL] [Abstract][Full Text] [Related]
16. mPEGylated solanesol micelles as redox-responsive nanocarriers with synergistic anticancer effect.
Qin B; Liu L; Wu X; Liang F; Hou T; Pan Y; Song S
Acta Biomater; 2017 Dec; 64():211-222. PubMed ID: 28963017
[TBL] [Abstract][Full Text] [Related]
17. Design and evaluation of galactosylated chitosan/graphene oxide nanoparticles as a drug delivery system.
Wang C; Zhang Z; Chen B; Gu L; Li Y; Yu S
J Colloid Interface Sci; 2018 Apr; 516():332-341. PubMed ID: 29408121
[TBL] [Abstract][Full Text] [Related]
18. Graphene aerogel nanoparticles for in-situ loading/pH sensitive releasing anticancer drugs.
Ayazi H; Akhavan O; Raoufi M; Varshochian R; Hosseini Motlagh NS; Atyabi F
Colloids Surf B Biointerfaces; 2020 Feb; 186():110712. PubMed ID: 31846894
[TBL] [Abstract][Full Text] [Related]
19. Controlled release of doxorubicin from graphene oxide based charge-reversal nanocarrier.
Zhou T; Zhou X; Xing D
Biomaterials; 2014 Apr; 35(13):4185-94. PubMed ID: 24513318
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of biologically-active reduced graphene oxide by using fucoidan as a multifunctional agent for combination cancer therapy.
Kang S; Hong YL; Ku BC; Lee S; Ryu S; Min DH; Jang H; Kim YK
Nanotechnology; 2018 Nov; 29(47):475604. PubMed ID: 30191889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
